These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 33548268)

  • 1. History in perspective: How Alzheimer's Disease came to be where it is?
    Ahmed TF; Ahmed A; Imtiaz F
    Brain Res; 2021 May; 1758():147342. PubMed ID: 33548268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
    Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R;
    Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Historic concepts of dementia and Alzheimer's disease: From ancient times to the present.
    Vatanabe IP; Manzine PR; Cominetti MR
    Rev Neurol (Paris); 2020 Mar; 176(3):140-147. PubMed ID: 31174886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].
    Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ;
    Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research diagnostic criteria for Alzheimer's disease: findings from the LipiDiDiet randomized controlled trial.
    Rosenberg A; Solomon A; Soininen H; Visser PJ; Blennow K; Hartmann T; Kivipelto M;
    Alzheimers Res Ther; 2021 Mar; 13(1):64. PubMed ID: 33766132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of the NIA-AA Research Framework: Towards a Biological Definition of Alzheimer's Disease Using Cerebrospinal Fluid Biomarkers in the AIBL Study.
    Burnham SC; Coloma PM; Li QX; Collins S; Savage G; Laws S; Doecke J; Maruff P; Martins RN; Ames D; Rowe CC; Masters CL; Villemagne VL
    J Prev Alzheimers Dis; 2019; 6(4):248-255. PubMed ID: 31686097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and management of Alzheimer's disease: past, present and future ethical issues.
    Gauthier S; Leuzy A; Racine E; Rosa-Neto P
    Prog Neurobiol; 2013 Nov; 110():102-13. PubMed ID: 23578568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is Alzheimer's disease? An analysis of nosological perspectives from the 20th and 21st centuries.
    Villain N; Michalon R
    Eur J Neurol; 2024 Nov; 31(11):e16302. PubMed ID: 38618742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early detection of Alzheimer's disease: new diagnostic criteria.
    Dubois B; Picard G; Sarazin M
    Dialogues Clin Neurosci; 2009; 11(2):135-9. PubMed ID: 19585949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease: learning from the past, looking to the future.
    Barreto Pde S
    Am J Alzheimers Dis Other Demen; 2013 Jun; 28(4):304-5. PubMed ID: 23677735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 100 Years of Alzheimer's disease (1906-2006).
    Lage JM
    J Alzheimers Dis; 2006; 9(3 Suppl):15-26. PubMed ID: 17004362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
    McKhann GM; Knopman DS; Chertkow H; Hyman BT; Jack CR; Kawas CH; Klunk WE; Koroshetz WJ; Manly JJ; Mayeux R; Mohs RC; Morris JC; Rossor MN; Scheltens P; Carrillo MC; Thies B; Weintraub S; Phelps CH
    Alzheimers Dement; 2011 May; 7(3):263-9. PubMed ID: 21514250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and risk of progression of preclinical Alzheimer's disease stages: a systematic review and meta-analysis.
    Parnetti L; Chipi E; Salvadori N; D'Andrea K; Eusebi P
    Alzheimers Res Ther; 2019 Jan; 11(1):7. PubMed ID: 30646955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical impact of (11)C-Pittsburgh compound-B positron emission tomography carried out in addition to magnetic resonance imaging and single-photon emission computed tomography on the diagnosis of Alzheimer's disease in patients with dementia and mild cognitive impairment.
    Omachi Y; Ito K; Arima K; Matsuda H; Nakata Y; Sakata M; Sato N; Nakagome K; Motohashi N
    Psychiatry Clin Neurosci; 2015 Dec; 69(12):741-51. PubMed ID: 26085054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Cerebrospinal Fluid Biomarkers in the Evolution of Diagnostic Criteria in Alzheimer's Disease: Shortcomings in Prodromal Diagnosis.
    Szalárdy L; Zádori D; Klivényi P; Vécsei L
    J Alzheimers Dis; 2016 May; 53(2):373-92. PubMed ID: 27163812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. History and experience: the direction of Alzheimer's disease.
    Reichman WE; Rose NS
    Menopause; 2012 Jul; 19(7):724-34. PubMed ID: 22735098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is a genetic cause? The example of Alzheimer's Disease.
    Dekkers W; Rikkert MO
    Med Health Care Philos; 2006; 9(3):273-84. PubMed ID: 16847726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
    Sperling RA; Aisen PS; Beckett LA; Bennett DA; Craft S; Fagan AM; Iwatsubo T; Jack CR; Kaye J; Montine TJ; Park DC; Reiman EM; Rowe CC; Siemers E; Stern Y; Yaffe K; Carrillo MC; Thies B; Morrison-Bogorad M; Wagster MV; Phelps CH
    Alzheimers Dement; 2011 May; 7(3):280-92. PubMed ID: 21514248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress update: fluid and imaging biomarkers in Alzheimer's disease.
    Sutphen CL; Fagan AM; Holtzman DM
    Biol Psychiatry; 2014 Apr; 75(7):520-6. PubMed ID: 24012326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.
    Vos SJ; Verhey F; Frölich L; Kornhuber J; Wiltfang J; Maier W; Peters O; Rüther E; Nobili F; Morbelli S; Frisoni GB; Drzezga A; Didic M; van Berckel BN; Simmons A; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Lovestone S; Muscio C; Herukka SK; Salmon E; Bastin C; Wallin A; Nordlund A; de Mendonça A; Silva D; Santana I; Lemos R; Engelborghs S; Van der Mussele S; ; Freund-Levi Y; Wallin ÅK; Hampel H; van der Flier W; Scheltens P; Visser PJ
    Brain; 2015 May; 138(Pt 5):1327-38. PubMed ID: 25693589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.